$AVNR Recent News
U.S. stock futures cut rise after retail sales 7:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 7:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 4:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 3:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 5:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 4:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 5:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 9:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 4:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 12:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 9:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 8:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 12:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 2:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 12:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy
Avanir Pharmaceuticals shares up 85% 8:41 a.m. Aug. 11, 2009 - Nick Godt
Avanir climbs on Phase III Zenvia trial success 6:31 a.m. Aug. 11, 2009 - Steve Goldstein
Avanir Pharmaceuticals (AVNR) Jumps: Stock Up 19.7% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Look For These Biotech Stocks To Move In 2014 11:14 a.m. Dec. 19, 2013 - Seeking Alpha
Mid-Afternoon Market Update: Markets Falling as Smith & Wesson Continues to Rise on Earnings 3:02 p.m. Dec. 11, 2013 - benzinga.com
Mid-Day Market Update: Smith & Wesson Gains On Upbeat Profit; LabCorp Shares Decline 11:29 a.m. Dec. 11, 2013 - benzinga.com
Summer Street defends Avanir after trial miss 10:38 a.m. Dec. 11, 2013 - Seeking Alpha
Mid-Morning Market Update: Markets Fall; Joy Global Profit Misses Estimates 10:37 a.m. Dec. 11, 2013 - benzinga.com
Avanir Reports Wider Loss - Analyst Blog 10:37 a.m. Dec. 11, 2013 - Zacks.com
Zacks #5 Rank Additions for Wednesday - Tale of the Tape 9:30 a.m. Dec. 11, 2013 - Zacks.com
Morning Market Losers 9:05 a.m. Dec. 11, 2013 - benzinga.com
Benzinga's Top #PreMarket Losers 7:34 a.m. Dec. 11, 2013 - benzinga.com
Benzinga's Top Downgrades 7:13 a.m. Dec. 11, 2013 - benzinga.com
Wednesday’s Biggest Stock Losers – AVNR, OPK and More 6:19 a.m. Dec. 11, 2013 - InvestorPlace.com
10-K: AVANIR PHARMACEUTICALS, INC. 6:09 a.m. Dec. 11, 2013 - Edgar Online - (EDG = 10Q, 10K)
Avanir's CEO Discusses F4Q 2013 Results - Earnings Call Transcript 8:08 p.m. Dec. 10, 2013 - Seeking Alpha
Avanir -13.8% AH, AVP-923 misses primary efficacy endpoint in phase II trial 5:36 p.m. Dec. 10, 2013 - Seeking Alpha
Q4 2013 AVANIR PHARMACEUTICALS Earnings Conference call (Webcast) 4:25 p.m. Dec. 10, 2013 - Seeking Alpha
Earnings Scheduled For December 10, 2013 4:14 a.m. Dec. 10, 2013 - benzinga.com
An Analysis Into Avanir Pharmaceuticals Neutralizes Concern And Reveals Potential 10:44 a.m. Dec. 9, 2013 - Seeking Alpha
Avanir Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Health Care Conference (Transcript) 12:26 p.m. Dec. 4, 2013 - Seeking Alpha
Avanir Pharmaceuticals' Management Presents at Deutsche Bank BioFEST Conference (Transcript) 11:43 a.m. Dec. 3, 2013 - Seeking Alpha
Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma 8:00 a.m. Dec. 18, 2013 - PR Newswire
Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health 8:00 a.m. Dec. 16, 2013 - PR Newswire
Technical Research on Equities: Zoetis, Actavis, Avanir Pharma, and Salix Pharma 8:00 a.m. Dec. 16, 2013 - PR Newswire
Important Stocks Scan List: Nokia Corporation, BlackBerry Ltd, Sprint Corporation, Avanir Pharmaceuticals 9:03 a.m. Dec. 11, 2013 - ACCESSWIRE
Avanir Pharmaceuticals Reports Fiscal 2013 Fourth Quarter Financial and Year-End Business Results 4:00 p.m. Dec. 10, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Results for Phase II PRIME Study 4:00 p.m. Dec. 10, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Date of Fiscal 2013 Fourth Quarter Financial Results and Conference Call 8:00 a.m. Dec. 3, 2013 - GlobeNewswire
Avanir Pharmaceuticals to Participate in Two Conferences in December 8:30 a.m. Nov. 26, 2013 - PR Newswire
Stock Price Update, Recognitions, and Grant of Stock Options - Research Report on Cyberonics, Hill-Rom Holdings, Bio-Reference Laboratories, Avanir Pharmaceuticals, and ImmunoGen 8:00 a.m. Nov. 21, 2013 - PR Newswire
Before the Bell Scans: Zoetis Inc., Avanir Pharma, Actavis PLC, and Salix Pharmaceuticals Ltd 8:01 a.m. Nov. 13, 2013 - PR Newswire
Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares 8:00 a.m. Nov. 11, 2013 - PR Newswire
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:00 p.m. Nov. 8, 2013 - PR Newswire
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information 7:30 a.m. Oct. 29, 2013 - PR Newswire
Recognitions, Patent Issuance, Financial Results, Upcoming Investor Conferences and Update on ClinicalTrial - Research Report on Stereotaxis, Immunomedics, Novadaq, Avanir, and Raptor Pharmaceuticals 8:00 a.m. Oct. 28, 2013 - PR Newswire
Technical Study: Zoetis Inc., AVANIR Pharma Inc., Actavis plc, and Salix Pharma Ltd 8:18 a.m. Oct. 24, 2013 - PR Newswire
Avanir Pharmaceuticals to Host Investor Day on October 29, 2013 7:30 a.m. Oct. 23, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease 7:30 a.m. Oct. 22, 2013 - PR Newswire
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3:15 p.m. Oct. 4, 2013 - PR Newswire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 10:48 a.m. Oct. 1, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache" 7:30 a.m. Sept. 20, 2013 - PR Newswire
U.S. stock futures cut rise after retail sales 7:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 7:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 4:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 3:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 5:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 4:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 5:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 9:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 4:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 12:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 9:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 8:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 12:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 2:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 12:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy
Avanir Pharmaceuticals shares up 85% 8:41 a.m. Aug. 11, 2009 - Nick Godt
Avanir climbs on Phase III Zenvia trial success 6:31 a.m. Aug. 11, 2009 - Steve Goldstein
Avanir Pharmaceuticals (AVNR) Jumps: Stock Up 19.7% - Tale of the Tape 8:51 a.m. Today - Zacks.com
Look For These Biotech Stocks To Move In 2014 11:14 a.m. Dec. 19, 2013 - Seeking Alpha
Mid-Afternoon Market Update: Markets Falling as Smith & Wesson Continues to Rise on Earnings 3:02 p.m. Dec. 11, 2013 - benzinga.com
Mid-Day Market Update: Smith & Wesson Gains On Upbeat Profit; LabCorp Shares Decline 11:29 a.m. Dec. 11, 2013 - benzinga.com
Summer Street defends Avanir after trial miss 10:38 a.m. Dec. 11, 2013 - Seeking Alpha
Mid-Morning Market Update: Markets Fall; Joy Global Profit Misses Estimates 10:37 a.m. Dec. 11, 2013 - benzinga.com
Avanir Reports Wider Loss - Analyst Blog 10:37 a.m. Dec. 11, 2013 - Zacks.com
Zacks #5 Rank Additions for Wednesday - Tale of the Tape 9:30 a.m. Dec. 11, 2013 - Zacks.com
Morning Market Losers 9:05 a.m. Dec. 11, 2013 - benzinga.com
Benzinga's Top #PreMarket Losers 7:34 a.m. Dec. 11, 2013 - benzinga.com
Benzinga's Top Downgrades 7:13 a.m. Dec. 11, 2013 - benzinga.com
Wednesday’s Biggest Stock Losers – AVNR, OPK and More 6:19 a.m. Dec. 11, 2013 - InvestorPlace.com
10-K: AVANIR PHARMACEUTICALS, INC. 6:09 a.m. Dec. 11, 2013 - Edgar Online - (EDG = 10Q, 10K)
Avanir's CEO Discusses F4Q 2013 Results - Earnings Call Transcript 8:08 p.m. Dec. 10, 2013 - Seeking Alpha
Avanir -13.8% AH, AVP-923 misses primary efficacy endpoint in phase II trial 5:36 p.m. Dec. 10, 2013 - Seeking Alpha
Q4 2013 AVANIR PHARMACEUTICALS Earnings Conference call (Webcast) 4:25 p.m. Dec. 10, 2013 - Seeking Alpha
Earnings Scheduled For December 10, 2013 4:14 a.m. Dec. 10, 2013 - benzinga.com
An Analysis Into Avanir Pharmaceuticals Neutralizes Concern And Reveals Potential 10:44 a.m. Dec. 9, 2013 - Seeking Alpha
Avanir Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Health Care Conference (Transcript) 12:26 p.m. Dec. 4, 2013 - Seeking Alpha
Avanir Pharmaceuticals' Management Presents at Deutsche Bank BioFEST Conference (Transcript) 11:43 a.m. Dec. 3, 2013 - Seeking Alpha
Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma 8:00 a.m. Dec. 18, 2013 - PR Newswire
Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health 8:00 a.m. Dec. 16, 2013 - PR Newswire
Technical Research on Equities: Zoetis, Actavis, Avanir Pharma, and Salix Pharma 8:00 a.m. Dec. 16, 2013 - PR Newswire
Important Stocks Scan List: Nokia Corporation, BlackBerry Ltd, Sprint Corporation, Avanir Pharmaceuticals 9:03 a.m. Dec. 11, 2013 - ACCESSWIRE
Avanir Pharmaceuticals Reports Fiscal 2013 Fourth Quarter Financial and Year-End Business Results 4:00 p.m. Dec. 10, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Results for Phase II PRIME Study 4:00 p.m. Dec. 10, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Date of Fiscal 2013 Fourth Quarter Financial Results and Conference Call 8:00 a.m. Dec. 3, 2013 - GlobeNewswire
Avanir Pharmaceuticals to Participate in Two Conferences in December 8:30 a.m. Nov. 26, 2013 - PR Newswire
Stock Price Update, Recognitions, and Grant of Stock Options - Research Report on Cyberonics, Hill-Rom Holdings, Bio-Reference Laboratories, Avanir Pharmaceuticals, and ImmunoGen 8:00 a.m. Nov. 21, 2013 - PR Newswire
Before the Bell Scans: Zoetis Inc., Avanir Pharma, Actavis PLC, and Salix Pharmaceuticals Ltd 8:01 a.m. Nov. 13, 2013 - PR Newswire
Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares 8:00 a.m. Nov. 11, 2013 - PR Newswire
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:00 p.m. Nov. 8, 2013 - PR Newswire
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information 7:30 a.m. Oct. 29, 2013 - PR Newswire
Recognitions, Patent Issuance, Financial Results, Upcoming Investor Conferences and Update on ClinicalTrial - Research Report on Stereotaxis, Immunomedics, Novadaq, Avanir, and Raptor Pharmaceuticals 8:00 a.m. Oct. 28, 2013 - PR Newswire
Technical Study: Zoetis Inc., AVANIR Pharma Inc., Actavis plc, and Salix Pharma Ltd 8:18 a.m. Oct. 24, 2013 - PR Newswire
Avanir Pharmaceuticals to Host Investor Day on October 29, 2013 7:30 a.m. Oct. 23, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease 7:30 a.m. Oct. 22, 2013 - PR Newswire
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3:15 p.m. Oct. 4, 2013 - PR Newswire
Today's Technical View: Avanir Pharmaceuticals Inc., Warner Chilcott PLC, Actavis Inc., and Dynavax Technologies Corp. 10:48 a.m. Oct. 1, 2013 - PR Newswire
Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache" 7:30 a.m. Sept. 20, 2013 - PR Newswire
